New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Weight loss predicts mortality in rheumatoid arthritis

Weight loss predicts mortality in rheumatoid arthritis

(HealthDay)—Weight loss is a strong predictor of mortality in patients with rheumatoid arthritis (RA), according to a study published online June 26 inArthritis & Rheumatology.Joshua F. Bake
Immunology & Rheumatology April 08,2024
Weight loss predicts mortality in rheumatoid arthritis

Weight loss predicts mortality in rheumatoid arthritis

(HealthDay)—Weight loss is a strong predictor of mortality in patients with rheumatoid arthritis (RA), according to a study published online June 26 inArthritis & Rheumatology.Joshua F. Bake
Immunology & Rheumatology April 08,2024
Weekly leflunomide effective for early rheumatoid arthritis

Weekly leflunomide effective for early rheumatoid arthritis

(HealthDay)—A higher, weekly dose of leflunomide shows similar benefits to a daily dose for the treatment of mild-to-moderate early rheumatoid arthritis (ERA), according to a study published online Au
Immunology & Rheumatology April 08,2024
Weekly leflunomide effective for early rheumatoid arthritis

Weekly leflunomide effective for early rheumatoid arthritis

(HealthDay)—A higher, weekly dose of leflunomide shows similar benefits to a daily dose for the treatment of mild-to-moderate early rheumatoid arthritis (ERA), according to a study published online Au
Immunology & Rheumatology April 08,2024
Vitamin D shows no impact on interferon response in SLE

Vitamin D shows no impact on interferon response in SLE

(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3supplementation does not affect interferon (IFN) signature, according to a study published in the July issue ofA
Immunology & Rheumatology April 08,2024
Vitamin D shows no impact on interferon response in SLE

Vitamin D shows no impact on interferon response in SLE

(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3supplementation does not affect interferon (IFN) signature, according to a study published in the July issue ofA
Immunology & Rheumatology April 08,2024
Gout is primary indication in about 0.2 percent of ER visits

Gout is primary indication in about 0.2 percent of ER visits

Gout is the primary indication in about 0.2 percent of emergency department visits annually, according to a study published online Sept. 4 inArthritis Care & Research.(HealthDay)—Gout is the
Immunology & Rheumatology April 08,2024
Gout is primary indication in about 0.2 percent of ER visits

Gout is primary indication in about 0.2 percent of ER visits

Gout is the primary indication in about 0.2 percent of emergency department visits annually, according to a study published online Sept. 4 inArthritis Care & Research.(HealthDay)—Gout is the
Immunology & Rheumatology April 08,2024
Inactivity and obesity relate to cognitive impairment in lupus

Inactivity and obesity relate to cognitive impairment in lupus

(HealthDay) -- Physical inactivity and obesity are associated with impaired cognitive function, especially executive functions, in women with systemic lupus erythematosus (SLE), according to research
Immunology & Rheumatology April 08,2024
Inactivity and obesity relate to cognitive impairment in lupus

Inactivity and obesity relate to cognitive impairment in lupus

(HealthDay) -- Physical inactivity and obesity are associated with impaired cognitive function, especially executive functions, in women with systemic lupus erythematosus (SLE), according to research
Immunology & Rheumatology April 08,2024
Teen vitamin D intake not related to adult RA or SLE risk

Teen vitamin D intake not related to adult RA or SLE risk

Dietary vitamin D intake during adolescence does not appear to be associated with the risk of adult-onset rheumatoid arthritis or systemic lupus erythematosus, according to research published in the D
Immunology & Rheumatology April 08,2024
Teen vitamin D intake not related to adult RA or SLE risk

Teen vitamin D intake not related to adult RA or SLE risk

Dietary vitamin D intake during adolescence does not appear to be associated with the risk of adult-onset rheumatoid arthritis or systemic lupus erythematosus, according to research published in the D
Immunology & Rheumatology April 08,2024
Prevalence of gout increases with increasing BMI

Prevalence of gout increases with increasing BMI

Having an increased body mass index correlates with increased prevalence of gout in adults, according to study published online July 6 inArthritis Care & Research.(HealthDay) -- Having an in
Immunology & Rheumatology April 08,2024
Prevalence of gout increases with increasing BMI

Prevalence of gout increases with increasing BMI

Having an increased body mass index correlates with increased prevalence of gout in adults, according to study published online July 6 inArthritis Care & Research.(HealthDay) -- Having an in
Immunology & Rheumatology April 08,2024
Allergies may plague renters more than homeowners

Allergies may plague renters more than homeowners

Those who rent less likely to take steps to reduce indoor allergy triggers, study finds .(HealthDay) -- People with common indoor allergies who rent their home are much less likely than homeowners to
Immunology & Rheumatology April 08,2024
Allergies may plague renters more than homeowners

Allergies may plague renters more than homeowners

Those who rent less likely to take steps to reduce indoor allergy triggers, study finds .(HealthDay) -- People with common indoor allergies who rent their home are much less likely than homeowners to
Immunology & Rheumatology April 08,2024
Multifactorial mechanisms underlie leg weakness in hip OA

Multifactorial mechanisms underlie leg weakness in hip OA

Multiple factors contribute to leg weakness in people with hip osteoarthritis, with muscle atrophy being the strongest contributor, according to the results of a systematic review published online Jul
Immunology & Rheumatology April 08,2024
Multifactorial mechanisms underlie leg weakness in hip OA

Multifactorial mechanisms underlie leg weakness in hip OA

Multiple factors contribute to leg weakness in people with hip osteoarthritis, with muscle atrophy being the strongest contributor, according to the results of a systematic review published online Jul
Immunology & Rheumatology April 08,2024
Women with lupus seem at higher risk for hip fractures

Women with lupus seem at higher risk for hip fractures

by Kathleen Doheny, Healthday ReporterStudy followed nearly 15,000 patients for 6 years.(HealthDay)—Women with lupus—the autoimmune disease that can damage skin, joints and organs—also are at higher r
Immunology & Rheumatology April 08,2024
Women with lupus seem at higher risk for hip fractures

Women with lupus seem at higher risk for hip fractures

by Kathleen Doheny, Healthday ReporterStudy followed nearly 15,000 patients for 6 years.(HealthDay)—Women with lupus—the autoimmune disease that can damage skin, joints and organs—also are at higher r
Immunology & Rheumatology April 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com